Efficacy and Safety of SPD503 in Combination With Psychostimulants

Completed · Phase 3 · Has a placebo group

Conditions studied: ADHD

In brief

The purpose of this study is to assess the efficacy and safety of SPD503 in subjects with ADHD when co-administered with psychostimulants in children and adolescents aged 6-17 years with a diagnosis of ADHD with a sub-optimal, partial response to stimulants.

Key facts

Study ID
NCT00734578
Run by
Shire
People needed
461
Starts
2008-09-02
Expected to finish
2009-12-10
Last updated by the study team
2021-06-14

Who can join

Age: 6 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.